Intervention not reported
Weight gain 6 months post‐intervention (mean X (kg) ± standard error SE) · children with measles infection and no clinically demonstrable vitamin A deficiency
1 finding from 1 review
Intervention not reported
Stillbirth · All pregnant women receiving either vitamin C supplementation or control either in areas where there is inadequate dietary intake or where…
The intervention showed no clear difference in stillbirth (moderate certainty).
1 finding from 1 review
Intervention not reported
Intrauterine growth restriction · All pregnant women receiving either vitamin C supplementation or control either in areas where there is inadequate dietary intake or where…
The intervention showed no clear difference in intrauterine growth restriction (high certainty).
1 finding from 1 review
Intervention not reported
Preterm birth (< 37 weeks' gestation) · All pregnant women receiving either vitamin C supplementation or control either in areas where there is inadequate dietary intake or where…
The intervention showed no clear difference in preterm birth (< 37 weeks' gestation) (high certainty).
1 finding from 1 review
Intervention not reported
Preterm prelabour rupture of membranes · All pregnant women receiving either vitamin C supplementation or control either in areas where there is inadequate dietary intake or where…
The intervention showed no clear difference in preterm prelabour rupture of membranes (low certainty).
1 finding from 1 review
Intervention not reported
Clinical pre‐eclampsia · All pregnant women receiving either vitamin C supplementation or control either in areas where there is inadequate dietary intake or where…
The intervention showed no clear difference in clinical pre‐eclampsia (moderate certainty).
1 finding from 1 review
Intervention not reported
Placental abruption · All pregnant women receiving either vitamin C supplementation or control either in areas where there is inadequate dietary intake or where…
The intervention leads to lower placental abruption (high certainty).
1 finding from 1 review
Mortality within the longest · patients with vitamin K antagonist‐induced bleeding requiring acute intervention
It is very uncertain whether prothrombin complex concentrate changes overall mortality ‐ longest compared with any comparator (very low certainty).
1 finding from 1 review
Number of new occurrences of RBC transfusion · patients with vitamin K antagonist‐induced bleeding requiring acute intervention
It is very uncertain whether prothrombin complex concentrate changes number of new occurrences of RBC transfusion compared with any comparator (very low certainty).
1 finding from 1 review
Number of complications probably related to the intervention · patients with vitamin K antagonist‐induced bleeding requiring acute intervention
It is very uncertain whether prothrombin complex concentrate changes number of complications probably related to the intervention compared with any comparator (very low certainty).
1 finding from 1 review
Transfusion of RBCs · patients with vitamin K antagonist‐induced bleeding requiring acute intervention
1 finding from 1 review
Major VTE events in TKR combined doses bilateral ascending venography · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors showed no clear difference in major VTE events in TKR combined doses bilateral ascending venography compared with vitamin K antagonists (low certainty).
1 finding from 1 review
All‐cause Mortality events in TKR combined doses · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors showed no clear difference in all‐cause Mortality events in TKR combined doses compared with vitamin K antagonists (low certainty).
1 finding from 1 review
Total Bleeding events in TKR combined doses · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors showed no clear difference in total Bleeding events in TKR combined doses compared with vitamin K antagonists (low certainty).
1 finding from 1 review
ALT >3 times the upper normal limit · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors showed no clear difference in ALT >3 times the upper normal limit at the end of compared with vitamin K antagonists (low certainty).
1 finding from 1 review
Serious adverse events · children with sickle cell anaemia and microalbuminuria
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality due to any cause · children with sickle cell anaemia and microalbuminuria
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · children with sickle cell anaemia and microalbuminuria
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reduction or prevention of kidney disease progression · children with sickle cell anaemia and microalbuminuria
1 finding from 1 review
All‐cause mortality · ambulatory patients with multiple myeloma receiving immunomodulatory agents
It is very uncertain whether aspirin (ASA) changes all‐cause mortality compared with vitamin K antagonist (VKA) (very low certainty).
2 findings from 1 review